Preliminary Study of Safety and Efficacy of Policosanol
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
Lay Language Summary: High cholesterol levels are common in persons with HIV infection.
However, conventional cholesterol-lowering medications may have harmful side effects when
given to HIV-infected persons. Therefore, we plan to evaluate the safety and effectiveness of
policosanol, a dietary supplement derived from sugar cane that has cholesterol-lowering
properties, to lower cholesterol levels in persons with HIV infection. We hypothesize that
policosanol will lower levels of LDL cholesterol ("bad" cholesterol) and raise levels of HDL
cholesterol ("good" cholesterol).
Phase:
Phase 2
Details
Lead Sponsor:
Rush University Medical Center
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)